オーダーセンター

オーダーセンターはこちらから

日本語SDS

日本語SDSをカタログ番号からご検索いただけます。

SAFCの原料・バルク・受託合成

カタログ掲載製品の原料・バルク供給、および各種化学品の受託合成を承ります。

Corporate

Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

お問い合わせ先一覧

7月1日より国内へ輸送中の製品に関する入庫情報をご案内できるようになりました!

カタログ請求

Request literature from Sigma-Aldrich

化合物検索

アルドリッチの約20万物質を部分構造式や用途・反応タイプ別に検索できます。

キャンペーン

お得なキャンペーン情報はこちら

カスタムオリゴのオーダー

カスタム(シグマジェノシス)製品。カスタムオリゴDNA, カスタムペプチド、カスタムポリクローナル抗体作製、カスタムsiRNA、プレデザインsiRNAなどを国内の合成拠点から迅速にお届けいたします。

News & Information

St. Louis, MO - October 16, 2014 BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy

BioReliance, Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services business under SAFC® Commercial, has introduced select in vitro ADME (absorption, distribution, metabolism and excretion) and toxicology testing services for pharmaceutical, chemical and industrial consumer products to its service offering.

Read More
St. Louis, MO - October 3, 2014 Sigma-Aldrich Agrees To Acquire Cell Marque To Strengthen Immunohistochemistry Business

Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that it has entered into an agreement to acquire Rocklin, California, based Cell Marque Corporation in a move to strengthen its antibody portfolio and to better serve immunohistochemistry (IHC) customers.

Read More
Japan - September 22, 2014 Merck KGaA to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

Merck KGaA, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, and Sigma-Aldrich today announced that they have entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.

プレスリリース全文(英語:206KB PDF)

日本語訳(260KB PDF)

Read More